Clash Of Drugs Impedes Lung Cancer Treatment, Lowers Survival

Corticosteroids are commonly prescribed to alleviate cancer-related symptoms in patients with non-small cell lung cancer, researchers said. But these steroids appear to dampen the effectiveness of immunotherapy against lung cancer, researchers report in Cancer Research Communications. High doses of steroids given before or during treatment with immune checkpoint inhibitors (ICIs), which are drugs that block cancer…

Read More

FDA Halts Sale of Off-Brand Ozempic and Other GLP-1 Drugs

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on. The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound). That means compounded versions of these drugs…

Read More

What’s Trump Done on Prescription Drug Prices So Far – and What Might Be Next?

Early moves by the president raise questions about what direction his second-term policy on drug costs will take. Amid a flurry of executive actions on his first day back in office, President Donald Trump gave the first official indications of his administration’s approach to health care by scrapping existing orders aimed at expanding health coverage under the Affordable Care Act and strengthening…

Read More